Minimal residual disease in myeloma – opportunities and controversies

About this seminar

Dr Roger Owen, Consultant Haematologist, St James’s Institute of Oncology, Leeds, explains the role of minimal residual disease in myeloma and discusses the opportunities and current controversies surrounding this hotly debated topic.

This presentation was filmed at the Myeloma Academy Haematologists Roadshow in Leeds.

CPD hours = 1

Take the CPD quiz